圣达生物：目前包括维生素、生物保鲜及功能配料在内的主要产品均已形成面向欧洲等海外市场的常态化出口布局

Group 1 - The company has successfully completed the EU CEP registration in 2024 and is focusing on global development as a strategic direction for long-term value growth [2] - The company has established a regular export layout for its main products, including vitamins, biological preservatives, and functional ingredients, targeting overseas markets such as Europe [2] - The revenue situation from these exports aligns with the company's overall pace of international expansion, indicating a strategic approach to market development [2] Group 2 - The company employs a flexible and diversified sales strategy, adapting its business operations based on different development stages and customer needs [2]